Vanda Pharmaceuticals VNDA Stock Analysis 172 Loss Key Levels 20260516 Chinese Investors With Few Options Turn to Dividends Redfin Announces Major Strategic Shift in Home Sales and Housing Market Approach Cross Country Healthcare to Be Acquired in 437 Million Deal